In head and neck squamous cell carcinoma (HNSCC), abnormal activation of the NRF2 pathway, often due to KEAP1 mutations or epigenetic alterations, has been closely associated with resistance to cisplatin and increased metastasis [112]. Here, NFE2L2 is linked to head and neck squamous cell carcinoma.